R&D tax reform - Lindsey Copland, Innovation Tax Partner
"The R&D tax regime has undergone reforms recently and while expected, the confirmation today that the Government will proceed with implementing a single scheme from 1 April 2024 means there's no respite for businesses in keeping up with legislative change.
The merged scheme will apply to expenditure incurred in accounting periods beginning on or after 1 April 2024 and will broadly follow the current RDEC rules, meaning all companies will benefit from the receipt of a tax credit that can be recognised ‘above-the-line’ as taxable income. Under the existing RDEC scheme, a notional tax at the main rate of corporation tax is applied to the RDEC for loss-making companies but under the new scheme the rate will be reduced to 19%, accelerating the RDEC cash benefit for loss-making businesses.
While the objective of the merged scheme is simplification, a second scheme for R&D intensive SMEs will run alongside it offering enhanced rates of relief for certain loss-making SMEs for expenditure incurred from 1 April 2023. It was previously announced that a company would be considered R&D intensive where its R&D expenditure accounted for at least 40% of its total deductible expenditure for the period, but the intensity threshold will be reduced to 30% for accounting periods commencing on or after 1 April 2024. A year’s grace rule will be introduced to help provide some certainty to claimants where their spend fluctuates.
Today’s announcements did provide some welcome clarity over the proposed restrictions under the merged scheme where R&D has been contracted out to a company. The intention appears to be that the party which makes the decision to undertake the R&D and bears the risk should get the benefit. A review of the Autumn Finance Bill 2023 (once released) will be required to understand the implications, and exceptions, around who can claim, which will depend upon the specific contract and fact pattern.
With these changes, businesses will need to act quickly to review their R&D claims, both in terms of the methodology and forecasting the future benefit. The need to understand the new merged scheme mechanism is likely to cause some operational headaches for those not used to the RDEC scheme, so it's essential for companies to work with advisers who are experienced in preparing RDEC claims. The Government have also stated that further action may be needed to deal with high levels of non-compliance, while remaining open to further enhance the R&D intensive support for SMEs.
With little time until the single scheme is implemented it's essential that the Government publish the proposed legislation, and accompanying guidance, as soon as possible to support businesses in their preparations."